MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/01.cir.0000012544.07696.1f

Медицинская библиотека · Circulation · 2002

Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome.

Sinisalo Juha, Mattila Kimmo, Valtonen Ville, Anttonen Olli, Juvonen Jukka, Melin John, Vuorinen-Markkola Helena, Nieminen Markku S, Clarithromycin in Acute Coronary Syndrome Patients in Finland (CLARIFY) Study Group

Клиническое исследованиеСтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Coronary artery disease, an inflammatory disease, may be caused by infection. We investigated whether the antibiotic clarithromycin would reduce morbidity and mortality in patients with acute non-Q-wave coronary syndrome.

METHODS AND

RESULTS

Altogether, 148 patients with acute non-Q-wave infarction or unstable angina were randomly assigned to receive double-blind treatment with either clarithromycin or placebo for 3 months. The primary end point was a composite of death, myocardial infarction, or unstable angina during treatment; the secondary end point was occurrence of any cardiovascular event during the entire follow-up period (average 555 days, range 138 to 924 days). There was a trend toward fewer patients meeting primary end-point criteria in the clarithromycin group than in the placebo group (11 versus 19 patients, respectively; risk ratio 0.54, 95% CI 0.25 to 1.14; P=0.10). By the end of the entire follow-up, 16 patients in the clarithromycin group and 27 in the placebo group had experienced a cardiovascular event (risk ratio 0.49, 95% CI 0.26 to 0.92; P=0.03).

CONCLUSIONS

Clarithromycin appears to reduce the risk of ischemic cardiovascular events in patients presenting with acute non-Q-wave infarction or unstable angina. No signs of this effect diminishing were observed during follow-up.

Для цитирования: Sinisalo Juha, Mattila Kimmo, Valtonen Ville, Anttonen Olli, Juvonen Jukka, Melin John, Vuorinen-Markkola Helena, Nieminen Markku S, Clarithromycin in Acute Coronary Syndrome Patients in Finland (CLARIFY) Study Group. Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome.. Circulation. 2002. DOI: 10.1161/01.cir.0000012544.07696.1f.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.